July 29, 2008


Wyeth's animal health division posts 12-percent revenue increase


US pharmaceutical company Wyeth's global animal health department has reported a 12-percent increase to US$313 million for Q2 ended June 30.


The higher income was due to increased sales of poultry and livestock products. The company also benefited from favourable exchange rates.


Overall, Wyeth reported a net income of US$1.12 billion on US$5.95 billion revenue for Q2, slightly below that of last year's Q2 earnings of US$1.2 billion on US$5.65 billion revenue.


Year to date, New Jersey-based Wyeth has reported a revenue increase of 6 percent to US$590 million.


One of the world's largest pharmaceutical companies, Wyeth manufactures pharmaceuticals, consumer health care and animal health care products, which are sold in more than 145 countries.

Video >

Follow Us